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Abstract
Introduction: IgAN occurs following abnormal IgA deposition in the glomerular mesangial regions. It is the most
common primary glomerular disease and one of the causes of ESRD, so it is necessary to identify clinical and histopathological ﬁndings that predict progression to ESRD. In the physiopathology of this disease, C4d causes serious renal
injuries and should be counted as a signiﬁcant prognostic factor too. This study examined C4d biomarker and compare it
with ﬁndings affecting prognosis, to determine the predictive value of C4d in progression to ESRD in IgAN.
Materials and methods: In this study, all biopsy samples of IgAN patients who referred to Imam Reza Hospital in Tabriz
were collected for four years. Their samples were evaluated C4d immunohistochemical staining and positive samples
have compared with Clinical-histopathological ﬁndings affecting prognosis.
Results: In this study, C4d positivity showed a signiﬁcant association with mesangial hypercellularity (p ¼ 0.001),
segmental glomerulosclerosis (p ¼ 0.003), and endocapillary hypercellularity (p ¼ 0.001); however, it did not show a
signiﬁcant relationship with tubular atrophy/interstitial ﬁbrosis (p ¼ 0.08). The study also found that C4d positivity was
signiﬁcantly (p < 0.05) correlated with hypertension, increased proteinuria, hematuria, high creatinine, and decreased
mean eGFR.
Conclusion: This study showed that immunohistochemical staining of C4d is a useful method for evaluating the
prognosis of the severity of renal injuries in patients with IgAN and could be a valuable alternative for most Clinicalhistopathological factors routinely used as predictive factors for its progression to ESRD, especially when the biopsy
specimen size is small and insufﬁcient for other studies.
Keywords: IgA nephropathy, C4d immunohistochemical staining

1. Introduction

I

gA nephropathy (IgAN) is one of the most
common primary glomerular diseases worldwide [1]. The disease is a type of proliferative
glomerulonephritis
that
occurs
following
abnormal IgA deposition in the mesangial region
of the glomeruli. In the physiopathology of this
disease, the complement system, especially the
subtype C4d, plays an essential but unknown role
by activating the lectin pathway [2]. On the other
hand, it has been observed that in patients with
activated lectin pathway, the risk of severe renal

failure is increased and is signiﬁcantly reduced
within ten years [3]. Based on this evidence, it
seems that C4d can be considered a signiﬁcant
prognostic factor as an indicator of lectin pathway
activation. This disease is one of the most leading
causes of end-stage renal disease (ESRD), so it is
crucial to identify Clinical-histopathological factors that predict progression to ESRD. These
factors include high blood pressure at the time of
diagnosis [4-6], Any increase in urine protein
concentrations especially values above 3.5 g in 24hour urine collection at the onset or persistence of
symptoms [4-12], persistent isolated hematuria at
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the time of symptoms [7, 8, 13, 14], high serum
creatinine levels [7, 8, 15-18], and decreased Mean
eGFR [7-10, 15, 19, 20] are among the factors that
predict poor prognosis for renal survival in patients with IgAN. There are some critical histological factors in determining the prognosis of IgA
nephropathy, including mesangial hypercellularity,
endocapillary
hypercellularity,
segmental glomerulosclerosis, and tubular atrophy/interstitial ﬁbrosis (abbreviated MEST),
which is associated with adverse renal outcomes
[21]. Renal biopsy is requisite for the diagnose of
IgA nephropathy [22]; however, due to the invasive nature of this procedure, as well as its
importance in determining prognosis in the
choice of treatment intensity at the onset of the
disease [23, 24] and the role of C4d subtype in the
induction of severe renal failure, it would be
necessary to unravel the role of C4d as a critical
prognostic factor, especially in cases where the
biopsy specimen size is small.

than 25% of the specimen to be included as positive
or cases [22], on the other hand, another histological
section was prepared and mounted on a charged
slide for immunohistochemical staining with a rabbit anti-C4d monoclonal IgG antibody (BioCare
Medical LLC). Specimens with strong and diffused
anti-C4d antibody deposition in 75% of glomeruli in
the mesangial region were known as positive cases
(Fig. 1) [26]. Clinical and laboratory ﬁndings
including high blood pressure (blood pressure 140/
90 mm Hg and higher at the time of diagnosis)
[4,26], proteinuria (excretion of over 400 mg of protein in 24-hour urine collection) [22]., persistent
positive hematuria (with þ1 dipstick strip or more
during two consecutive urinalysis tests [7, 8, 13, 14]،,
high creatinine (serum creatinine concentration
above 1.4 mg/dL) [8] and eGFR1 reduction (60-90
ml/min per 1.73 m2 of body surface area as mild
reduction, 30-60 ml/min per 1.73 m2 of body surface
area as an average reduction, and less than 30 ml/
min per 1.73 m2 of body surface area as severe
reduction) [7-10, 15, 19, 20] that collected based on
physical examination and laboratory testing at the
beginning of referred.

2. Materials and Methods

2.1. Statistical analysis

In this study, all patients with renal diseases who
referred to Imam Reza Hospital in Tabriz were sent
to the Pathology Department of this hospital between March 2015 and September 2019. The selection of the biopsy specimen was based on IgAN
conﬁrmation by immunoﬂuorescence (IF) studies.
The inclusion criteria of biopsy specimens were 1)
The severity of IgA depositions 2þ [22] and
negative C1q depositions in the IF studies [25]., 2)
having at least six glomeruli that ﬁxed in formalin
10% [22] and evaluated by hematoxylin and eosin
(H&E) staining. For the analysis of the histological
criteria according to the Oxford classiﬁcation, nine
serial sections from each specimen were providing
and staining by H&E, Jones' methenamine silver,
Periodic acideSchiff (PAS) [22]. The criteria
included the presence of mesangial hypercellularity
(more than 50% of glomeruli must have more than
three mesangial cells as positive Specimens or
cases) [22], segmental glomerulosclerosis (any
amount of glomerular sclerosis as positive or cases)
[22], endocapillary hyperplasia (any amount of
hypercellularity in endocapillary areas as positive
Specimens or cases) [22], and tubular atrophy/
interstitial ﬁbrosis (if present it must have more

Demographic, clinical, and laboratory data were
evaluated retrospectively. Statistical analysis was
carried out using SPSS software version 21.0. Based

1

Fig. 1. Positive immunohistochemical staining of C4d. Strong immunoreactivity and diffused C4d deposition are evident in the glomerular
mesangial region (400 magniﬁcation).

eGFR (ml/min per 1.73 m2)¼(186 x serum creatinine-1.154) x (age-0.203) x (0.742 if female) x (1.21 if black).

ORIGINAL ARTICLE

BioMedicine
2021;11(2):18e23

20

T. POURLAK ET AL
C4D STAINING IN IGA NEPHROPATHY

BioMedicine
2021;11(2):18e23

ORIGINAL ARTICLE

on the qualitative and quantitative nature of the test,
the results were analyzed using Pearson or
Spearman tests. Finally, the data were depicted in
the form of Tables and Figures.

3. Results
Out of a total of 51 patients with IgAN, only 48
met the required criteria to be included in our
study. The age range of patients was between 15
and 63 years, and most of them were in the age
range of 30 to 40 years, with a frequency of 33.3%.
Among patients, 66.7% were male, and 33.3% were
female. Among IgAN patients, 29 patients (60.4%)
were immunohistochemically positive for C4d,
while 19 patients (39.6%) were negative for this
protein. In our study, there was a direct, strong,
and signiﬁcant correlation between the association
of
mesangial
hypercellularity,
endocapillary
hypercellularity, and segmental glomerulosclerosis
with C4d immunoreactivity in patients with IgAN
(P < 0.05). It was also shown that most IgAN patients who were immunohistochemically positive
for C4d were signiﬁcantly more likely to have
mesangial hypercellularity, endocapillary hypercellularity, and segmental glomerulosclerosis in
renal histological specimens (P < 0.05) (Table 1). In
our study, although most patients with IgAN who
were positive for C4d had tubular atrophy/interstitial ﬁbrosis in renal biopsy specimens, such a
correlation was not statistically signiﬁcant (P-value
¼ 0.081) (Table 1). The statistical analysis showed
that there was a signiﬁcant association between
decreased eGFR and increased immunoreactivity
for C4d marker in patients with IgAN (P-value ¼
0.032), as the mean eGFR was 52.00 ml/min for
patients who were positive for C4d, while it was
68.053 ml/min for patients who were negative for
this marker (Table 2). Besides, a direct, strong, and
signiﬁcant correlation was detected between the
association of high blood pressure with C4d
immunoreactivity in patients with IgAN (P-value ¼
0.000) (Fig. 2). It has also been shown that most
IgAN patients who were positive for C4d also had

signiﬁcantly higher values of (P-value ¼ 0.012)
(Table 5). Our ﬁndings demonstrated a direct,
strong, and signiﬁcant correlation between hematuria and C4d immunoreactivity in patients with
IgAN (P-value ¼ 0.01) (Fig. 2). It was also shown
that most IgAN patients who were positive for C4d
in immunohistochemical evaluations were signiﬁcantly more likely to have hematuria (P-value ¼
0.0005) (Table 5). Also, a direct, strong, and significant association was found between high creatinine levels and C4d immunoreactivity in patients
with IgAN (P-value ¼ 0.000) (Table 3). It was also
indicated that most IgAN patients who were positive for C4d in immunohistochemical assessments
also had signiﬁcantly higher concentrations of
creatinine (P-value ¼ 0.005) (Table 5). On the other
hand, the results showed that IgAN patients who
were positive for C4d in immunohistochemical
evaluations had a higher average creatinine level
compared with patients who were negative for this
marker (2.05 mg/dl vs. 1.22 mg/dl) (Table 3). The
results showed a direct, strong, and signiﬁcant
relationship between proteinuria with C4d immunoreactivity in patients with IgAN (P-value ¼ 0.000)
(Table 4). It was also shown that most IgAN patients who were positive for C4d also had a signiﬁcant extent of proteinuria (P-value ¼ 0.000)
(Table 5). Our study indicated that IgAN patients
who were positive for C4d also had a higher
average protein excretion in their urine compared
with C4d-negative patients (2.24 g/day vs. 1.09 g/
day) (Table 4).

4. Discussion
IgA nephropathy is a common kidney disease
that, through IgA deposition and with various
mechanisms such as C4d deposition in the kidney
leads to changes in clinical and histopathologic
signs for the patient, and play an important role in
the future for prediction of prognosis of the disease.
In this investigation, we tried to study the predictive
value of C4d as a new marker in association with
other criteria affecting prognosis.

Table 1. Relationship between histopathologic factors and C4d immunoreactivity.
Histological

Category

C4 d
Positive

Negative

Mesangial hypercellularity

Positive
Negative
Positive
Negative
Positive
Negative
Positive
Negative

23 (82.1%)
6 (30%)
20 (87%)
9 (36%)
23 (79.3%)
6 (31.6%)
15 (75%)
14 (50%)

5 (17.9%)
14 (70%)
3 (13%)
16 (64%)
6 (20.7%)
13 (68.4%)
5 (25%)
14 (50%)

Endocapillary proliferation
Segmental glomerulosclerosis
The proportional of tubular/atrophy and interstitial ﬁbrosis

P-Value

Chi-Square

0.000

13.264

0.000

13.006

0.001

10.936

0.081

3.049
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Table 2. The association between eGFR and C4d immunoreactivity.
eGFR

C4d

Positive
Negative

Spearman Correlation

>60

30-60

30>

P-Value

Phi

10 (45.5%)
12 (54.5%)

12 (66.7%)
5 (33.3%)

7 (87.5%)
1 (12.5%)

0.032

0.311

Mean ± S D
52.00 ± 25.53
68.053 ± 22.9

Fig. 2. Comparison of Clinical-pathology factors with C4d immunoreactivity.

Table 3. The relationship between creatinine and C4d immunoreactivity.
Creatinine

C4d Positive
C4d Negative

Mean ± SD

Pearson Correlation

Creatinine positive

Creatinine negative

Chi-Square

P-Value

Phi

24 (85.7%)
4 (14.3%)

5 (25%)
15 (75%)

17.938

0.000

0.612

2.05 ± 1.15
1.22 ± 0.37

Table 4. The correlation between proteinuria and C4d immunoreactivity.
Proteinuria

C4d

Positive
Negative

Mean ± SD

Correlation test
results

Proteinuria positive

Proteinuria negative

P-Value

Phi

27 (93.1%)
12 (30.8%)

2 (6.9%)
7 (77.8%)

0.000

0.517

C4d plays a signiﬁcant role in activating the lectin
pathway [2], and by producing a variety of pro-inﬂammatory mediators, it causes mesangial hypercellularity [27, 28] as well as focal And or segmental
glomerulosclerosis [3]. On the other hand, subendothelial C4d deposits [22], especially in the
glomerular area [29], can lead to damage to podocytes through endocapillary proliferation [22]. As a
result, the association between C4d and histological
factors affecting prognosis in our study and other
studies [26,30e32] suggests a negative effect of C4d
on prognosis. However, the association between
C4d positivity and tubular atrophy/interstitial
ﬁbrosis in the present research, unlike other studies

2.24 ± 1.32
1.09 ± 1.25

[26,30e32], could be due to the higher speciﬁcity of
the monoclonal antibody used in our study. However, higher positive C4d cases in the study group
without tubular atrophy/interstitial ﬁbrosis may be
because of more important than C4d deposition in
glomerular damage than extra-glomerular injury
[29], as well as concomitant glomerular damage with
tubular atrophy and interstitial ﬁbrosis in positive
C4d cases. Glomerular C4d deposition, followed by
renal failure [34], impairs glomerular ﬁltration, and
increases serum creatinine as two factors affecting
prognosis. Our study, similar to other studies
[26,31,33], showed that C4d positivity with a
decrease in mean eGFR to less than 60 ml/min
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Table 5. Relationship between Clinic-histopathologic factors in patients with positive C4d based on the binomial distribution.
Mesangial hypercellularity
Endocapillary proliferation
Segmental glomerulosclerosis
Hypertension
Hematuria
Creatinine
Proteinuria

Positive
Negative
Positive
Negative
Positive
Negative
Positive
Negative
Positive
Negative
Positive
Negative
Positive
Negative

Frequency C4d positive

Observed Proportion

P-Value

23
6
20
9
23
6
21
8
24
5
24
5
27
2

79%
21%
69%
31%
79%
21%
72%
28%
83%
17%
83%
17%
93%
7%

0.001

caused signiﬁcant destruction in renal function. Our
study, similar to other studies, showed that C4d
positivity with a decrease in mean eGFR to less than
60 ml/min caused signiﬁcant destruction in renal
function. On the other hand, according to our study
and other previous researches [32] [26], C4d-negative patients had an average creatinine excretion of
less than 1.25 mg/dl, while C4d-positive patients
had a moderate creatinine level above 1.68 mg/dl,
which according to previous studies can respectively lead to ESRD by 2.5% and 71%, within ten
years [8]. The co-occurrence between C4d positivity
and high blood pressure in our study and other
investigations [26,31,33] can be exhibited severity
renal injury in the kidney of IgAN patients. C4d
deposits in the mesangial area can probably be
through the proliferation of mesangial cells, secretion of extracellular matrix components [35]. Previous studies showed C4dstaining was more
correlative with the endocapillary proliferation
score of the Oxford classiﬁcation, than with the
mesangial changes [36]. Increased expression of
bTGF, and activation of the renin-angiotensin system [37-39] lead to hypertension, renal injury and
ﬁnally poor prognosis in the IgAN patients. The
present study conﬁrmed the concurrence of C4d
deposition and hematuria. The emergence of hematuria at the time of the beginning of disease may
be correlated with a higher risk of ESRD in the
future [7, 8, 13, 14]. Also, the presence of RBCs inside the tubules, as a result of hematuria, causes
severe injuries to the kidneys by causing acute
tubular necrosis [7, 8, 13, 14]. Therefore, regardless
of the damage mechanism of hematuria, a positive
C4d will adversely inﬂuence the patient's prognosis.
Our study, similar to other studies [26,31,33],
showed that C4d negativity causes average proteinuria of about 1 gram per day, whereas C4d
positivity leads to an increase in proteinuria of more

0.003
0.001
0.012
0.0005
0.005
0.000

than 1 gram per day. Such an effect stems from C4d
glomerular deposition and the resulting glomerular
damage [34]. Therefore, due to the negative effect of
proteinuria increase on prognosis, a positive C4d
will result in a poor prognosis for the patient.
Finally, it can be inferred that C4d is a useful
biomarker in assessing the prognosis of the severity
of renal injury in IgAN patients and could be a
worthy alternative to most clinical-histopathological
factors predicting the progression towards ESRD.
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